Jazz Pharmaceuticals plc (Nasdaq: JAZZ), a global biopharmaceutical company, is dedicated to developing medicines for people with limited or no options, so they can live their lives more fully and redefine what is possible. As a leader in sleep medicine and with a growing hematology/oncology portfolio, Jazz has a diverse portfolio of products and product…
About Blueprint Medicines Blueprint Medicines is a precision therapy company striving to improve human health. With a focus on genomically defined cancers, rare diseases and cancer immunotherapy, we are developing transformational medicines rooted in our leading expertise in protein kinases, which are proven drivers of disease. Our uniquely targeted, scalable approach empowers the rapid design and…
Deciphera Pharmaceuticals Deciphera Pharmaceuticals is focused on discovering, developing, and bringing important new medicines to patients for the treatment of cancer. Enabled by our proprietary kinase switch control inhibitor platform, our drug candidates are designed to stop cancers from growing and spreading by inhibiting mutant forms or over expression of a family of enzymes…
Epizyme’s vision is to rewrite treatment for cancer and other serious diseases through novel epigenetic medicines. Epizyme aspires to change the standard of care for patients and physicians by developing medicines with fundamentally new mechanisms of action. Learn more Epizyme.com. Patient Assistance & Product Support: EpizymeNOW 1-833-4EPI(NOW) (437-4669)
Founded in March 2015, EUSA Pharma is a profitable specialty pharmaceutical company with global reach from its headquarters in the UK and its commercial operations across Europe and the USA. EUSA Pharma is a rapidly growing while staying focused in oncology and rare disease. Our mission at EUSA is that we are passionate and committed…
COMPANY OVERVIEW Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to build a leading biopharmaceutical company focused on improving the lives of cancer patients by developing and commercializing novel first-in-class therapeutics. In December…
Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. We are driven by the strength, tenacity and courage of those battling cancer – single-minded in our resolve to deliver new therapies that not only keep cancer at bay, but…
Rigel Pharmaceuticals, Inc. is a South San Francisco-based biopharmaceutical company focused on discovering, developing, and providing novel therapies that enhance the lives of people with immune and hematological disorders, cancers, and rare diseases. Rigel’s clinical development programs span multiple disease targets including chronic immune thrombocytopenia, autoimmune hemolytic anemia and others. Rigel’s first FDA approved product…
Servier Pharmaceuticals is a commercial-stage pharmaceuticals company with a passion for innovation and improving the lives of patients, their families and caregivers. In the United States, Servier Pharmaceuticals is committed to building a robust portfolio, starting with oncology, with future growth driven by innovation in other areas of unmet medical need, leveraging Servier’s global portfolio…
Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has an approved oncology precision medicine and multiple first-in-class investigational therapies in clinical and/or preclinical…
At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents. Our goal is to build on therapeutics with well-known pharmacology by improving their safety and efficacy as well…
Walgreens and AllianceRX Walgreens Prime are focused on expert cancer care. Our pharmacists and pharmacy technicians, who have advanced cancer training and expertise, go beyond filling prescriptions. Whether it’s making limited-distribution drugs accessible, helping connect eligible patients to financial assistance or providing adherence services, our team understands the needs of people living with cancer and…
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our development programs are targeted at specific subsets of cancer, combining personalized medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from them.
The STAR (Spectrum Therapy Access Resources) Co-pay Program will provide the following co-pay assistance to eligible patients, across the Spectrum portfolio: First Date of Service: Patient will have a $0 patient out of pocket. STAR will cover 100% of the co-insurance/ cost share for the Spectrum product. Subsequent Dates of Service: Patient will be responsible…
Ipsen Biopharmaceuticals and its research and development team are part of an innovation-driven international specialty pharmaceutical group (the Ipsen Group), with global headquarters in Paris and US headquarters in Basking Ridge, NJ (commercial/marketing), and Massachusetts (research and development). The global company markets more than 20 drugs and employs nearly 4,600 people around the world. Ipsen…
© 2020 FLASCO | Premium Website Design by The HDG
